These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 385638)

  • 1. Long-term sotalol therapy in patients with arrhythmias.
    Simon A; Berman E
    J Clin Pharmacol; 1979; 19(8-9 Pt 2):547-56. PubMed ID: 385638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful termination of combined rapid atrial flutter/fibrillation and ventricular tachycardia by intravenous sotalol.
    Ramsdale DR; Peterson C
    Postgrad Med J; 1987 Jul; 63(741):579-80. PubMed ID: 3658868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effectiveness and safety of d,l-sotalol in the ambulatory treatment of atrial fibrillation and flutter].
    Cruz Cruz F; Iturralde Torres P; Picos Bovio E; Medeiros Domingo A; Infante Vázquez O
    Arch Inst Cardiol Mex; 1998; 68(6):482-91. PubMed ID: 10365224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, safety, and tolerance of d-sotalol in patients with refractory supraventricular tachyarrhythmias.
    Sahar DI; Reiffel JA; Bigger JT; Squatrito A; Kidwell GA
    Am Heart J; 1989 Mar; 117(3):562-8. PubMed ID: 2919535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.
    Fitton A; Sorkin EM
    Drugs; 1993 Oct; 46(4):678-719. PubMed ID: 7506652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of sotalol in patients with refractory atrial fibrillation or flutter.
    Gallik DM; Kim SG; Ferrick KJ; Roth JA; Fisher JD
    Am Heart J; 1997 Aug; 134(2 Pt 1):155-60. PubMed ID: 9313591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sotalol: An important new antiarrhythmic.
    Anderson JL; Prystowsky EN
    Am Heart J; 1999 Mar; 137(3):388-409. PubMed ID: 10047618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias.
    Gettes LS
    Cardiovasc Clin; 1970; 2(2):211-37. PubMed ID: 4149974
    [No Abstract]   [Full Text] [Related]  

  • 9. Sotalol infusion in the treatment of supraventricular tachyarrhythmias.
    Teo KK; Harte M; Horgan JH
    Chest; 1985 Jan; 87(1):113-8. PubMed ID: 3965254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs.
    Antman EM; Beamer AD; Cantillon C; McGowan N; Friedman PL
    J Am Coll Cardiol; 1990 Mar; 15(3):698-707. PubMed ID: 2303641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group.
    Sung RJ; Tan HL; Karagounis L; Hanyok JJ; Falk R; Platia E; Das G; Hardy SA
    Am Heart J; 1995 Apr; 129(4):739-48. PubMed ID: 7900626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required? Yield of in-hospital monitoring and prediction of risk for significant arrhythmia complications.
    Chung MK; Schweikert RA; Wilkoff BL; Niebauer MJ; Pinski SL; Trohman RG; Kidwell GA; Jaeger FJ; Morant VA; Miller DP; Tchou PJ
    J Am Coll Cardiol; 1998 Jul; 32(1):169-76. PubMed ID: 9669266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic, pharmacokinetic and antiarrhythmic properties of d-sotalol, the dextro-isomer of sotalol.
    Advani SV; Singh BN
    Drugs; 1995 May; 49(5):664-79. PubMed ID: 7601009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical role of d-sotalol and d,l-sotalol in supraventricular arrhythmias, including pre-excitation.
    Daubert C; Mabo P; Gras D; Leclercq C
    Eur Heart J; 1993 Nov; 14 Suppl H():67-73. PubMed ID: 7904939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of electrophysiologically guided sotalol therapy for life-threatening ventricular arrhythmias.
    Lee RJ; Wong M; Siu A; Namekawa-Wong M; Epstein LM; Fitzpatrick AP; Grogin HR; Scheinman MM; Lesh MD
    Am Heart J; 1996 Nov; 132(5):973-8. PubMed ID: 8892770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of Sotalol (Darob) therapy in ventricular arrhythmias.
    Toporan D; Stancu M; Glodan D
    Rom J Intern Med; 1999; 37(1):31-41. PubMed ID: 15523943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug therapy of cardiac arrhythmias 199].
    Dietz A; Manz M
    Fortschr Med; 1997 Nov; 115(33):32, 34-6, 38. PubMed ID: 9480278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of oral sotalol during both sinus rhythm and atrial fibrillation.
    Alboni P; Razzolini R; Scarfò S; Paparella N; Fucà G; Pedini I; Chioin R
    J Am Coll Cardiol; 1993 Nov; 22(5):1373-7. PubMed ID: 8227794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Sotalol on clinical arrhythmias.
    Prakash R; Parmley WW; Allen HN; Matloff JM
    Am J Cardiol; 1972 Mar; 29(3):397-400. PubMed ID: 4110596
    [No Abstract]   [Full Text] [Related]  

  • 20. From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials.
    Lazzara R
    Am J Cardiol; 1996 Aug; 78(4A):28-33. PubMed ID: 8780326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.